##gff-version 3
##sequence-region Q9Y2K1 1 713
Q9Y2K1	UniProtKB	Chain	1	713	.	.	.	ID=PRO_0000047707;Note=Zinc finger and BTB domain-containing protein 1	
Q9Y2K1	UniProtKB	Domain	24	91	.	.	.	Note=BTB;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00037	
Q9Y2K1	UniProtKB	Zinc finger	216	242	.	.	.	Note=C2H2-type 1%3B atypical;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
Q9Y2K1	UniProtKB	Zinc finger	448	470	.	.	.	Note=C2H2-type 2%3B atypical;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
Q9Y2K1	UniProtKB	Zinc finger	533	558	.	.	.	Note=UBZ-type;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:24657165;Dbxref=PMID:24657165	
Q9Y2K1	UniProtKB	Zinc finger	578	600	.	.	.	Note=C2H2-type 4;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
Q9Y2K1	UniProtKB	Zinc finger	606	628	.	.	.	Note=C2H2-type 5;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
Q9Y2K1	UniProtKB	Zinc finger	634	656	.	.	.	Note=C2H2-type 6;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
Q9Y2K1	UniProtKB	Zinc finger	662	684	.	.	.	Note=C2H2-type 7;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
Q9Y2K1	UniProtKB	Zinc finger	686	709	.	.	.	Note=C2H2-type 8;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
Q9Y2K1	UniProtKB	Modified residue	355	355	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q9Y2K1	UniProtKB	Modified residue	356	356	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q9Y2K1	UniProtKB	Cross-link	3	3	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q9Y2K1	UniProtKB	Cross-link	200	200	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q9Y2K1	UniProtKB	Cross-link	205	205	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q9Y2K1	UniProtKB	Cross-link	260	260	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q9Y2K1	UniProtKB	Cross-link	265	265	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:25755297,ECO:0000244|PubMed:25772364,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:25755297,PMID:25772364,PMID:28112733	
Q9Y2K1	UniProtKB	Cross-link	275	275	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:25218447;Dbxref=PMID:25218447	
Q9Y2K1	UniProtKB	Cross-link	283	283	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q9Y2K1	UniProtKB	Cross-link	303	303	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q9Y2K1	UniProtKB	Cross-link	316	316	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q9Y2K1	UniProtKB	Cross-link	328	328	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:25755297,ECO:0000244|PubMed:25772364,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:25755297,PMID:25772364,PMID:28112733	
Q9Y2K1	UniProtKB	Cross-link	340	340	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q9Y2K1	UniProtKB	Cross-link	346	346	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q9Y2K1	UniProtKB	Cross-link	381	381	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q9Y2K1	UniProtKB	Cross-link	528	528	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q9Y2K1	UniProtKB	Cross-link	563	563	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q9Y2K1	UniProtKB	Alternative sequence	633	713	.	.	.	ID=VSP_040976;Note=In isoform 2. RYVCSICDQGNFRKHDHVRHMISHLSAGETICQVCFQIFPNNEQLEQHMDVHLYTCGICGAKFNLRKDMRSHYNAKHLKRT->SGEIGPSKPVEK;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:10231032;Dbxref=PMID:10231032	
Q9Y2K1	UniProtKB	Mutagenesis	265	265	.	.	.	Note=Reduces sumoylation. Inhibits transcriptional repressive activity. Inhibits sumoylation and reduces transcriptional repressive activity%3B when associated with R-328. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20797634;Dbxref=PMID:20797634	
Q9Y2K1	UniProtKB	Mutagenesis	325	325	.	.	.	Note=Reduces sumoylation of Lys-328. I->S	
Q9Y2K1	UniProtKB	Mutagenesis	326	326	.	.	.	Note=Reduces sumoylation of Lys-328. I->N	
Q9Y2K1	UniProtKB	Mutagenesis	328	328	.	.	.	Note=Reduces sumoylation. Does not reduce transcriptional repressive activity. Inhibits sumoylation but does not reduce transcriptional repressive activity%3B when associated with R-265. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20797634;Dbxref=PMID:20797634	
Q9Y2K1	UniProtKB	Mutagenesis	536	536	.	.	.	Note=Abolishes binding to ubiquitin%3B Abolishes recruitment to DNA lesion sites. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24657165;Dbxref=PMID:24657165	
Q9Y2K1	UniProtKB	Mutagenesis	539	539	.	.	.	Note=Abolishes binding to ubiquitin%3B Abolishes recruitment to DNA lesion sites. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24657165;Dbxref=PMID:24657165	
Q9Y2K1	UniProtKB	Sequence conflict	203	203	.	.	.	Note=T->N;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9Y2K1	UniProtKB	Sequence conflict	334	334	.	.	.	Note=I->T;Ontology_term=ECO:0000305;evidence=ECO:0000305	
